Grail GRAL
NASDAQ GRAL
$80.77 +0.82 (+1.03%)
At close: Sep 18, 2026 · 4:00 PM EDT

Grail (GRAL) Research & Development (2023 - 2026)

Grail's (GRAL) quarterly Research & Development came in at $47.4 million in Q2 2026, up 1.72% on a YoY basis from $46.6 million in Q2 2025, and down 1.23% quarter-over-quarter from $48.0 million in Q1 2026.

Analysis

Grail (GRAL) Research & Development (2023 - 2026) Analysis & Trends

Grail (GRAL) has reported Research & Development for 4 consecutive years, with $47.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Research & Development rose 1.72% year-over-year to $47.4 million; the trailing twelve-month figure through Jun 2026 stood at $190.7 million (down 15.91% YoY), and the FY2025 full-year result was $195.8 million, down 39.27% from the prior year.
  • Research & Development retreated to $47.4 million in Q2 2026 per GRAL's latest filing, from $48.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $323.2 million in Q4 2023 and bottomed at $36.6 million in Q4 2023.
  • Historically, Research & Development has averaged $80.6 million across 4 years, with a median of $48.5 million in 2024.
  • The widest YoY moves for Research & Development: up 131.23% in 2024, down 85.05% in 2024.
  • Over 4 years, Research & Development stood at $323.2 million in 2023, then tumbled by 85.05% to $48.3 million in 2024, then advanced by 0.66% to $48.6 million in 2025, then slipped by 2.5% to $47.4 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered $47.4 million, $48.0 million, and $48.6 million for Q2 2026, Q1 2026, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 228.07 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn -
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn -
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn 189.95 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 52.64 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn 53.76 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn -
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 17.32 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 26.41 Mn
10 Grail 3.61 Bn 2.75 Bn 21.34 Mn 47.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47.43 Mn
Mar 31, 2026 48.02 Mn
Sep 30, 2025 48.65 Mn
Jun 30, 2025 46.63 Mn
Mar 31, 2025 53.63 Mn
Dec 31, 2024 48.33 Mn
Sep 30, 2024 78.23 Mn
Jun 30, 2024 94.20 Mn
Mar 31, 2024 101.63 Mn
Dec 31, 2023 323.24 Mn
Oct 1, 2023 36.60 Mn
Jun 30, 2023 40.74 Mn